Insider / Roivant Sciences Ltd.
Sukhatme Mayukh
President & CIO at Roivant Sciences Ltd.
- Company
- Roivant Sciences Ltd.
- Ticker
- ROIV
- First filing on record
- December 19, 2025
- Latest trade on record
- October 16, 2026
- SEC filings
- EDGAR ↗
Sukhatme Mayukh, President & CIO at Roivant Sciences Ltd., has disclosed 49 transactions in ROIV since December 19, 2025: 0 purchases (0 open-market buys) and 18 sales, worth about $241.0M at the reported prices. The latest was filed October 20, 2026, 4 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Sukhatme Mayukh made no purchases and 18 sales worth $119M, plus 31 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Sukhatme Mayukh has traded 1 stock on record; the largest by dollars is ROIV.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 10 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 27 | 13,183,892 | $72.3M |
| S | Open-market sale | 13 | 3,697,140 | $109.1M |
| F | Shares withheld for tax | 5 | 331,054 | $10.0M |
| J | Other acquisition or disposal | 4 | 2,212,166 | $49.6M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 37 | 0 | 15 · $89.6M |
| 2025 | 12 | 0 | 3 · $29.5M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIV | Sell F | October 16, 2026 | October 20, 2026 | 4d | 19,976 | $34 | $670K | Form 4 ↗ | ||
| ROIV | Sell F | September 30, 2026 | October 2, 2026 | 2d | 46,879 | $37 | $1.7M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 21, 2026 | August 21, 2026 | 0d | 144,756 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | August 20, 2026 | August 21, 2026 | 1d | 17,519 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | August 19, 2026 | August 21, 2026 | 2d | 172,899 | — | — | derivative | Form 4 ↗ | |
| ROIV | Sell S | August 21, 2026 | August 21, 2026 | 0d | 144,756 | $36 | $5.3M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 21, 2026 | August 21, 2026 | 0d | 144,756 | $4 | $557K | Form 4 ↗ | ||
| ROIV | Sell S | August 20, 2026 | August 21, 2026 | 1d | 17,519 | $37 | $653K | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 20, 2026 | August 21, 2026 | 1d | 17,519 | $4 | $67K | Form 4 ↗ | ||
| ROIV | Sell S | August 19, 2026 | August 21, 2026 | 2d | 172,899 | $37 | $6.4M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 19, 2026 | August 21, 2026 | 2d | 172,899 | $4 | $666K | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 18, 2026 | August 18, 2026 | 0d | 136,942 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | August 17, 2026 | August 18, 2026 | 1d | 284,707 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 243,177 | — | — | derivative | Form 4 ↗ | |
| ROIV | Sell S | August 18, 2026 | August 18, 2026 | 0d | 31,801 | $37 | $1.2M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 18, 2026 | August 18, 2026 | 0d | 31,801 | $4 | $122K | Form 4 ↗ | ||
| ROIV | Sell S | August 18, 2026 | August 18, 2026 | 0d | 105,141 | $37 | $3.8M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 18, 2026 | August 18, 2026 | 0d | 105,141 | $4 | $405K | Form 4 ↗ | ||
| ROIV | Sell S | August 17, 2026 | August 18, 2026 | 1d | 284,707 | $36 | $10.3M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 17, 2026 | August 18, 2026 | 1d | 284,707 | $4 | $1.1M | Form 4 ↗ | ||
| ROIV | Sell S | August 14, 2026 | August 18, 2026 | 4d | 243,177 | $36 | $8.8M | Form 4 ↗ | ||
| ROIV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 243,177 | $4 | $936K | Form 4 ↗ | ||
| ROIV | Sell F | June 30, 2026 | July 2, 2026 | 2d | 46,878 | $35 | $1.7M | Form 4 ↗ | ||
| ROIV | Option / conversion M | June 26, 2026 | June 29, 2026 | 3d | 500,000 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | June 25, 2026 | June 29, 2026 | 4d | 500,000 | — | — | derivative | Form 4 ↗ | |
| ROIV | Sell S | June 26, 2026 | June 29, 2026 | 3d | 500,000 | $34 | $17.0M | Form 4 ↗ | ||
| ROIV | Option / conversion M | June 26, 2026 | June 29, 2026 | 3d | 500,000 | $4 | $1.9M | Form 4 ↗ | ||
| ROIV | Sell S | June 25, 2026 | June 29, 2026 | 4d | 500,000 | $34 | $17.1M | Form 4 ↗ | ||
| ROIV | Option / conversion M | June 25, 2026 | June 29, 2026 | 4d | 500,000 | $4 | $1.9M | Form 4 ↗ | ||
| ROIV | Option / conversion M | March 30, 2026 | April 1, 2026 | 2d | 1,306,889 | $12 | $15.0M | derivative | Form 4 ↗ | |
| ROIV | Sell F | March 31, 2026 | April 1, 2026 | 1d | 187,512 | $28 | $5.2M | Form 4 ↗ | ||
| ROIV | Sell F | March 30, 2026 | April 1, 2026 | 2d | 29,809 | $26 | $787K | Form 4 ↗ | ||
| ROIV | Option / conversion M | March 30, 2026 | April 1, 2026 | 2d | 58,391 | — | — | Form 4 ↗ | ||
| ROIV | Option / conversion M | February 9, 2026 | February 11, 2026 | 2d | 651,558 | — | — | derivative | Form 4 ↗ | |
| ROIV | Other J | February 9, 2026 | February 11, 2026 | 2d | 312,117 | $26 | $8.3M | Form 4 ↗ | ||
| ROIV | Sell S | February 9, 2026 | February 11, 2026 | 2d | 339,441 | $26 | $9.0M | Form 4 ↗ | ||
| ROIV | Option / conversion M | February 9, 2026 | February 11, 2026 | 2d | 651,558 | $13 | $8.3M | Form 4 ↗ | ||
| ROIV | Option / conversion M | December 31, 2025 | December 31, 2025 | 0d | 2,449,877 | — | — | derivative | Form 4 ↗ | |
| ROIV | Option / conversion M | December 29, 2025 | December 31, 2025 | 2d | 748,358 | — | — | derivative | Form 4 ↗ | |
| ROIV | Other J | December 31, 2025 | December 31, 2025 | 0d | 1,430,882 | $22 | $31.1M | Form 4 ↗ | ||
| ROIV | Sell S | December 31, 2025 | December 31, 2025 | 0d | 1,018,995 | $22 | $22.1M | Form 4 ↗ | ||
| ROIV | Option / conversion M | December 31, 2025 | December 31, 2025 | 0d | 2,449,877 | $13 | $31.1M | Form 4 ↗ | ||
| ROIV | Other J | December 29, 2025 | December 31, 2025 | 2d | 436,485 | $22 | $9.5M | Form 4 ↗ | ||
| ROIV | Sell S | December 29, 2025 | December 31, 2025 | 2d | 311,873 | $22 | $6.8M | Form 4 ↗ | ||
| ROIV | Option / conversion M | December 29, 2025 | December 31, 2025 | 2d | 748,358 | $13 | $9.5M | Form 4 ↗ | ||
| ROIV | Option / conversion M | December 17, 2025 | December 19, 2025 | 2d | 59,513 | — | — | derivative | Form 4 ↗ | |
| ROIV | Other J | December 17, 2025 | December 19, 2025 | 2d | 32,682 | $23 | $755K | Form 4 ↗ | ||
| ROIV | Sell S | December 17, 2025 | December 19, 2025 | 2d | 26,831 | $23 | $620K | Form 4 ↗ | ||
| ROIV | Option / conversion M | December 17, 2025 | December 19, 2025 | 2d | 59,513 | $13 | $755K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 20, 2026 | Form 4 | 0001635088-26-000114 | 1 | published | EDGAR ↗ |
| October 2, 2026 | Form 4 | 0001635088-26-000109 | 1 | published | EDGAR ↗ |
| August 21, 2026 | Form 4 | 0001140361-26-034066 | 9 | published | EDGAR ↗ |
| August 18, 2026 | Form 4 | 0001140361-26-033637 | 11 | published | EDGAR ↗ |
| July 2, 2026 | Form 4 | 0001635088-26-000075 | 1 | published | EDGAR ↗ |
| June 29, 2026 | Form 4 | 0001635088-26-000073 | 6 | published | EDGAR ↗ |
| April 1, 2026 | Form 4 | 0001635088-26-000033 | 4 | published | EDGAR ↗ |
| February 11, 2026 | Form 4 | 0001635088-26-000015 | 4 | published | EDGAR ↗ |
| December 31, 2025 | Form 4 | 0001140361-25-047122 | 8 | published | EDGAR ↗ |
| December 19, 2025 | Form 4 | 0001140361-25-046247 | 4 | published | EDGAR ↗ |
Other insiders at Roivant Sciences Ltd.
- Venker Eric President & Immunovant CEO 94 rows
- Gold Daniel Allen Director 22 rows
- MANCHESTER KEITH S Director 22 rows
- Gline Matthew CEO 20 rows
- Epperly Melissa B, Director 19 rows
- QVT Financial LP Insider 19 rows
- Fitzgerald Meghan Director 18 rows
- Torti Frank President and Vant Chair 17 rows
- Ramaswamy Vivek Insider 15 rows
- Pulik Richard CFO 14 rows
Everyone on file, with contracts and lobbying under the company's name: Roivant Sciences Ltd..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 10 | 49 | December 19, 2025 | October 20, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.